Related Experiment Video

Updated: Feb 21, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K

Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience

Yuan Yuan, Susan E Yost, John Yim

    Oncotarget
    |October 6, 2017
    PubMed

    Abstract:

    [This corrects the article DOI: 10.18632/oncotarget.14476.].

    More Related Videos

    Experimental Metastasis Assay
    08:28

    Experimental Metastasis Assay

    Published on: August 24, 2010

    21.0K
    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    19.0K

    Related Experiment Videos

    Last Updated: Feb 21, 2026

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    8.0K
    Experimental Metastasis Assay
    08:28

    Experimental Metastasis Assay

    Published on: August 24, 2010

    21.0K
    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    19.0K

    Related Concept Videos

    Cancer02:18

    Cancer

    54.8K
    Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
    54.8K
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.8K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    Incidence, Risk Factors, and Survival Implications of Immune-Related Adverse Events in Patients With Metastatic Breast Cancer.

    Clinical breast cancer·2026

    GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort study.

    The oncologist·2026

    Multi-state modeling associates proliferation genes with early estrogen receptor-positive breast cancer recurrence and survival.

    Research square·2026

    Baseline gene expression and dynamic endocrine therapy use in ER+ breast cancer: associations with recurrence in a real-world cohort.

    Research square·2026

    The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided care.

    Cell reports. Medicine·2026

    Case report: durable response to osimertinib, radiotherapy, and chemotherapy combination in advanced non-small cell lung cancer with atypical metastasis.

    Translational lung cancer research·2026

    Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine.

    Oncotarget·2026

    Systematic methodological flaws in DNA contamination assessment of mRNA vaccines: A critical analysis of Achs et al. (2025).

    Oncotarget·2026

    Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers.

    Oncotarget·2026

    WIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers.

    Oncotarget·2026

    Renal oncocytoma: Α case report and literature review.

    Oncotarget·2026

    TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer.

    Oncotarget·2026

    Locoregional recurrence after transaxillary robotic thyroidectomy for differentiated thyroid cancer: long-term outcomes in 10,504 patients.

    Surgical endoscopy·2026

    A multivariable model for treatment duration in nonextraction clear aligner therapy.

    American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics·2026

    Expanding the scope of platinum-NHC complexes: trans-Pt(II) and Pt(0) architectures for ovarian cancer treatment.

    Dalton transactions (Cambridge, England : 2003)·2026

    Oral Anticoagulation Monotherapy vs Dual-Pathway Antithrombotic Therapy in Chronic Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

    East meets west: resectable gastric cancer treatment in the era of immune checkpoint inhibitors.

    Expert opinion on pharmacotherapy·2026

    Perspectives on the use of coercion in highly specialised rehabilitation: a focus group study.

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us